Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana.
SkinCare Physicians, Chestnut Hill, Massachusetts.
Dermatol Surg. 2021 Apr 1;47(4):522-525. doi: 10.1097/DSS.0000000000002908.
No validated assessment tools are available to evaluate patient-reported outcomes specifically related to submental fat (SMF).
To develop and validate scales measuring the severity (Patient-Reported SMF Rating Scale [PR-SMFRS]) and psychological impact (Patient-Reported SMF Impact Scale [PR-SMFIS]) of SMF.
A literature review, content validation interviews (concept elicitation [n = 29] and cognitive debriefing [n = 15]) in adults with SMF, and expert interviews (n = 3) were conducted to develop the PR-SMFRS and PR-SMFIS. Psychometric validity (acceptability, reliability, and validity) for the PR-SMFRS and PR-SMFIS was assessed using data from 1 phase 2 and 5 phase 3 ATX-101 studies in patients with excess SMF.
The PR-SMFRS was constructed as a single-item, 5-point rating of the SMF amount/size. The PR-SMFIS was constructed as a 6-item scale, with an 11-point numeric rating for each item. Both scales demonstrated acceptable psychometric properties (test-retest reliability and internal consistency). The anchor-based minimally important difference analysis suggests a 1-point improvement on the PR-SMFRS (scale of 0‒4) and a 3-point improvement on the PR-SMFIS (scale of 0‒10) represent clinically meaningful change.
The PR-SMFRS and PR-SMFIS are reliable, valid instruments for assessing the severity and psychosocial impact, respectively, of SMF and detecting clinically meaningful change with intervention.
目前尚无经过验证的评估工具可用于评估与颏下脂肪(SMF)相关的患者报告结局。
开发和验证用于评估 SMF 严重程度(患者报告的颏下脂肪严重程度评分[PR-SMFRS])和心理影响(患者报告的颏下脂肪影响评分[PR-SMFIS])的量表。
进行文献回顾、有 SMF 的成年人的内容验证访谈(概念发掘[n=29]和认知性访谈[n=15])以及专家访谈(n=3),以制定 PR-SMFRS 和 PR-SMFIS。使用来自 ATX-101 治疗颏下脂肪过多的 1 项 2 期和 5 项 3 期研究的数据评估 PR-SMFRS 和 PR-SMFIS 的心理测量学有效性(可接受性、信度和效度)。
PR-SMFRS 构建为一个 5 分制的单项评分,用于评估 SMF 的数量/大小。PR-SMFIS 构建为一个 6 项量表,每项的数值评分范围为 11 分。这两个量表均具有可接受的心理测量学特性(重测信度和内部一致性)。基于锚定的最小重要差异分析表明,PR-SMFRS(0‒4 分制)提高 1 分和 PR-SMFIS(0‒10 分制)提高 3 分代表有临床意义的改善。
PR-SMFRS 和 PR-SMFIS 是可靠且有效的工具,可分别评估 SMF 的严重程度和心理社会影响,并检测干预后的临床意义变化。